Although data are limited to only three reported cases (17), sirolimus has demonstrated marked efficacy in children with CD25 deficiency, showing significant improvement in dermatitis and even reversal of diabetes when initiated early in the disease course. This evidence concerns the gene IL2RA and dermatitis.